세계의 화학요법 시장 - 산업 규모, 점유율, 동향, 기회, 예측 : 유형별, 적응증별, 제형별, 투여 경로별, 최종 사용자별, 지역별, 경쟁별(2020-2030년)
Chemotherapy Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Type, By Indication, By Dosage Form, By Route of Administration, By End User, By Region & Competition, 2020-2030F
상품코드:1785181
리서치사:TechSci Research
발행일:2025년 08월
페이지 정보:영문 180 Pages
라이선스 & 가격 (부가세 별도)
ㅁ Add-on 가능: 고객의 요청에 따라 일정한 범위 내에서 Customization이 가능합니다. 자세한 사항은 문의해 주시기 바랍니다.
한글목차
세계의 화학요법 시장은 2024년에 82억 6,000만 달러로 평가되었으며, 예측기간에서는 2030년까지 연평균 복합 성장률(CAGR) 8.51%를 나타내 눈부신 성장이 예상됩니다.
세계보건기구(WHO)의 발표에 따르면 암은 세계 2위 사망 원인이며 2018년 사망자 수는 960만명이었습니다. 암 이환율의 상승을 고려하면 화학요법의 의약품에 대한 수요는 높아질 것으로 보입니다. 화학요법은 체내에서 급속하게 분열하는 세포를 표적으로 하여 배제하는 강력한 화학물질을 이용한 암 치료법입니다. 암세포의 수를 줄이고 암 진행을 방해하고 종양을 축소시키는 효과가 증명되었습니다. 예를 들어 WHO2025에 따르면 국제암 연구기관(IARC)은 세계 암 이환율의 상승을 보고하고 있으며, 충분한 치료를 받을 수 없는 사람들이 가장 영향을 받고 있습니다. 115개국을 대상으로 한 조사에서는 대부분의 국가가 국민 모두 보험제도 중에서 우선되는 암이나 완화 케어에 충분한 자금을 제공하고 있지 않다는 것이 밝혀졌습니다. 이 조사 결과는 보다 강력한 의료 제도에 대한 투자를 통해 세계 암 의료의 불공평에 대처하는 긴급한 필요성을 강조하고 있습니다.
시장 개요
예측 기간
2026-2030년
시장 규모 : 2024년
82억 6,000만 달러
시장 규모 : 2030년
133억 8,000만 달러
CAGR : 2025-2030년
8.51%
급성장 부문
알킬화제
최대 시장
북미
화학요법은 단독 또는 병용으로 투여되는 경우가 많으며 광범위한 암에 대한 다용도가 높은 치료 수단입니다. 1차 치료 또는 단독 치료로서 숨어 있는 암세포를 제거하고 방사선이나 수술 등의 다른 치료에 대비합니다. 또한 암세포를 선택적으로 표적으로 함으로써 암과 관련된 징후와 증상을 완화할 수도 있습니다.
주요 시장 성장 촉진요인
암 이환율 상승
주요 시장 과제
치료비 급등
주요 시장 동향
파괴적 혁신적인 기술 개발
목차
제1장 개요
제2장 조사 방법
제3장 주요 요약
제4장 고객의 목소리
제5장 세계의 화학요법 시장 전망
시장 규모와 예측
금액별
시장 점유율·예측
유형별(알킬화제, 항대사물질, 항종양 항생제, 호르몬, 단일클론항체, 기타)
적응증별(종양학/암, 골수 질환 유형, 면역계 장애, 기타)
제형별(캡슐, 정제, 주사제, 기타)
투여 경로별(경구, 비경구, 기타)
최종 사용자별(병원, 전문 클리닉, 기타)
지역별
기업별(2024년)
시장 맵
제6장 북미의 화학요법 시장 전망
시장 규모와 예측
시장 점유율·예측
북미 : 국가별 분석
미국
캐나다
멕시코
제7장 유럽의 화학요법 시장 전망
시장 규모와 예측
시장 점유율·예측
유럽 : 국가별 분석
독일
영국
이탈리아
프랑스
스페인
제8장 아시아태평양의 화학요법 시장 전망
시장 규모와 예측
시장 점유율·예측
아시아태평양 : 국가별 분석
중국
인도
일본
한국
호주
제9장 남미의 화학요법 시장 전망
시장 규모와 예측
시장 점유율·예측
남미 : 국가별 분석
브라질
아르헨티나
콜롬비아
제10장 중동 및 아프리카의 화학요법 시장 전망
시장 규모와 예측
시장 점유율·예측
중동 및 아프리카 : 국가별 분석
남아프리카
사우디아라비아
아랍에미리트(UAE)
제11장 시장 역학
성장 촉진요인
과제
제12장 시장 동향과 발전
최근 동향
합병과 인수
제13장 세계의 화학요법 시장 : SWOT 분석
제14장 경쟁 구도
F. Hoffmann-La Roche Ltd.
Mylan NV
Teva Pharmaceutical Industries Ltd.
Sanofi
Pfizer Inc.
GlaxoSmithKline plc
Novartis AG
Bayer AG
Eli Lilly and Company
Merck & Co., Inc.
제15장 전략적 제안
제16장 기업 소개와 면책사항
KTH
영문 목차
영문목차
Global Chemotherapy Market was valued at USD 8.26 Billion in 2024 and is anticipated to project impressive growth in the forecast period with a CAGR of 8.51% through 2030. Cancer, as stated by the World Health Organization (WHO), is the second leading cause of mortality worldwide, resulting in an estimated 9.6 million deaths in 2018. Given the rising cancer rates, there will be an increased demand for chemotherapy medications. Chemotherapy is a cancer treatment approach that utilizes potent chemicals to target and eliminate rapidly dividing cells within the body. It has proven efficacy in reducing cancer cell count, impeding cancer progression, and shrinking tumors. For instance, according to WHO 2025, the International Agency for Research on Cancer (IARC) reported a rising global cancer burden, with underserved populations most affected. A survey across 115 countries revealed that most do not adequately fund priority cancer and palliative care within universal health coverage. The findings underscore the urgent need to address cancer care inequities worldwide through stronger health system investments.
Market Overview
Forecast Period
2026-2030
Market Size 2024
USD 8.26 Billion
Market Size 2030
USD 13.38 Billion
CAGR 2025-2030
8.51%
Fastest Growing Segment
Alkylating Agents
Largest Market
North America
Chemotherapy, often administered alone or in combination, is a versatile treatment modality for a wide range of cancers. It serves as a primary or sole treatment, eliminating hidden cancer cells and preparing patients for other interventions such as radiation or surgery. It can be employed to alleviate cancer-related signs and symptoms by selectively targeting cancer cells.
Key Market Drivers
Rising Incidences of Cancers
The increasing prevalence of cancer is projected to drive the growth rate of the chemotherapy drug market. According to NIH 2025, incidence rates of certain cancers have risen among individuals under age 50. However, despite this increase, overall cancer-related deaths in younger populations have not shown a corresponding rise. This suggests improvements in early detection, treatment options, and awareness, highlighting the importance of continued research and personalized care for younger cancer patients. Chemotherapy, often used in conjunction with other cancer treatments, remains the predominant approach to cancer treatment. Neo-adjuvant chemotherapy refers to chemotherapy administered prior to surgery and radiation therapy to reduce tumor size, while adjuvant chemotherapy is administered after surgery or radiation therapy to further shrink the tumor.
Key Market Challenges
High Cost of Treatment
The high cost associated with chemotherapy drugs poses a significant obstacle to the growth of the market. High chemotherapy costs can create financial barriers for patients, leading to delayed or deferred treatment, non-adherence to prescribed regimens, and reduced treatment effectiveness. Patients with limited financial resources may face disparities in accessing chemotherapy treatments, exacerbating existing healthcare inequalities. High costs can influence patients' treatment decisions, potentially leading to suboptimal choices based on financial considerations rather than medical necessity. The financial strain of chemotherapy can lead to reduced treatment access, particularly for uninsured or underinsured patients. The shortage of skilled professionals and inadequate healthcare infrastructure in developing economies present challenges to the chemotherapy drug market. The side effects of these drugs, including heart problems, decreased red blood cell count, fatigue, weight loss, hair loss, diarrhea, reduced lung, kidney, and liver function, decreased bone density, and limited awareness among the public, act as restraints and further hinder the market.
Key Market Trends
Development of Innovative Technology
Chemotherapy has played a pivotal role in extending the lifespan of cancer patients, surpassing their expected survival by several years. The latest breakthrough in the field of chemotherapy involves the administration of specially designed nanoparticles containing cancer-fighting medications, which selectively target affected areas while sparing healthy cells. This innovative approach has demonstrated remarkable efficacy in eradicating malignant cells while preserving surrounding healthy tissue. By utilizing photon lasers, medical professionals are able to precisely monitor the release, duration, and distribution of these medication-loaded nanoparticles within the patient's body. Excitingly, the University of California, Los Angeles, is currently conducting a clinical trial to evaluate the effectiveness of this approach, which has shown promising outcomes in the treatment of early-stage cancer patients. With its imminent entry into the chemotherapeutic market, this groundbreaking technique holds great potential for transforming cancer treatment.
Key Market Players
Hoffmann-La Roche Ltd.
Mylan N.V.
Teva Pharmaceutical Industries Ltd.
Sanofi
Pfizer Inc.
GlaxoSmithKline plc
Novartis AG
Bayer AG
Eli Lilly and Company
Merck & Co., Inc.
Report Scope:
In this report, the Global Chemotherapy Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:
Chemotherapy Market, By Type:
Alkylating Agents
Anti-metabolites
Anti-Tumor Antibiotics
Hormones
Monoclonal Antibodies
Others
Chemotherapy Market, By Indication:
Oncology/Cancer
Bone Marrow Diseases
Immune System Disorders
Others
Chemotherapy Market, By Dosage Form:
Capsule
Tablets
Injections
Others
Chemotherapy Market, By Route of Administration:
Oral
Parenteral
Others
Chemotherapy Market, By End User:
Hospitals
Specialty Clinics
Others
Chemotherapy Market, By Region:
North America
United States
Canada
Mexico
Europe
France
United Kingdom
Italy
Germany
Spain
Asia-Pacific
China
India
Japan
Australia
South Korea
South America
Brazil
Argentina
Colombia
Middle East & Africa
South Africa
Saudi Arabia
UAE
Competitive Landscape
Company Profiles: Detailed analysis of the major companies present in the Global Chemotherapy Market.
Available Customizations:
Global Chemotherapy market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:
Company Information
Detailed analysis and profiling of additional market players (up to five).
Table of Contents
1. Product Overview
1.1. Market Definition
1.2. Scope of the Market
1.2.1. Markets Covered
1.2.2. Years Considered for Study
1.2.3. Key Market Segmentations
2. Research Methodology
2.1. Objective of the Study
2.2. Baseline Methodology
2.3. Key Industry Partners
2.4. Major Association and Secondary Sources
2.5. Forecasting Methodology
2.6. Data Triangulation & Validations
2.7. Assumptions and Limitations
3. Executive Summary
3.1. Overview of the Market
3.2. Overview of Key Market Segmentations
3.3. Overview of Key Market Players
3.4. Overview of Key Regions/Countries
3.5. Overview of Market Drivers, Challenges, Trends
4. Voice of Customer
5. Global Chemotherapy Market Outlook
5.1. Market Size & Forecast
5.1.1. By Value
5.2. Market Share & Forecast
5.2.1. By Type (Alkylating Agents, Anti-metabolites, Anti-Tumor Antibiotics, Hormones, Monoclonal Antibodies, Others)
5.2.2. By Indication (Oncology/Cancer, Bone Marrow Diseasestype, Immune System Disorders, Others)
5.2.3. By Dosage Form (Capsule, Tablets, Injections, Others)
5.2.4. By Route of Administration (Oral, Parenteral, Others)
5.2.5. By End User (Hospitals, Specialty Clinics, Others)
5.2.6. By Region
5.2.7. By Company (2024)
5.3. Market Map
6. North America Chemotherapy Market Outlook
6.1. Market Size & Forecast
6.1.1. By Value
6.2. Market Share & Forecast
6.2.1. By Type
6.2.2. By Indication
6.2.3. By Dosage Form
6.2.4. By Route of Administration
6.2.5. By End Users
6.2.6. By Country
6.3. North America: Country Analysis
6.3.1. United States Chemotherapy Market Outlook
6.3.1.1. Market Size & Forecast
6.3.1.1.1. By Value
6.3.1.2. Market Share & Forecast
6.3.1.2.1. By Type
6.3.1.2.2. By Indication
6.3.1.2.3. By Dosage Form
6.3.1.2.4. By Route of Administration
6.3.1.2.5. By End Users
6.3.2. Canada Chemotherapy Market Outlook
6.3.2.1. Market Size & Forecast
6.3.2.1.1. By Value
6.3.2.2. Market Share & Forecast
6.3.2.2.1. By Type
6.3.2.2.2. By Indication
6.3.2.2.3. By Dosage Form
6.3.2.2.4. By Route of Administration
6.3.2.2.5. By End Users
6.3.3. Mexico Chemotherapy Market Outlook
6.3.3.1. Market Size & Forecast
6.3.3.1.1. By Value
6.3.3.2. Market Share & Forecast
6.3.3.2.1. By Type
6.3.3.2.2. By Indication
6.3.3.2.3. By Dosage Form
6.3.3.2.4. By Route of Administration
6.3.3.2.5. By End Users
7. Europe Chemotherapy Market Outlook
7.1. Market Size & Forecast
7.1.1. By Value
7.2. Market Share & Forecast
7.2.1. By Type
7.2.2. By Indication
7.2.3. By Dosage Form
7.2.4. By Route of Administration
7.2.5. By End Users
7.2.6. By Country
7.3. Europe: Country Analysis
7.3.1. Germany Chemotherapy Market Outlook
7.3.1.1. Market Size & Forecast
7.3.1.1.1. By Value
7.3.1.2. Market Share & Forecast
7.3.1.2.1. By Type
7.3.1.2.2. By Indication
7.3.1.2.3. By Dosage Form
7.3.1.2.4. By Route of Administration
7.3.1.2.5. By End Users
7.3.2. United Kingdom Chemotherapy Market Outlook
7.3.2.1. Market Size & Forecast
7.3.2.1.1. By Value
7.3.2.2. Market Share & Forecast
7.3.2.2.1. By Type
7.3.2.2.2. By Indication
7.3.2.2.3. By Dosage Form
7.3.2.2.4. By Route of Administration
7.3.2.2.5. By End Users
7.3.3. Italy Chemotherapy Market Outlook
7.3.3.1. Market Size & Forecast
7.3.3.1.1. By Value
7.3.3.2. Market Share & Forecasty
7.3.3.2.1. By Type
7.3.3.2.2. By Indication
7.3.3.2.3. By Dosage Form
7.3.3.2.4. By Route of Administration
7.3.3.2.5. By End Users
7.3.4. France Chemotherapy Market Outlook
7.3.4.1. Market Size & Forecast
7.3.4.1.1. By Value
7.3.4.2. Market Share & Forecast
7.3.4.2.1. By Type
7.3.4.2.2. By Indication
7.3.4.2.3. By Dosage Form
7.3.4.2.4. By Route of Administration
7.3.4.2.5. By End Users
7.3.5. Spain Chemotherapy Market Outlook
7.3.5.1. Market Size & Forecast
7.3.5.1.1. By Value
7.3.5.2. Market Share & Forecast
7.3.5.2.1. By Type
7.3.5.2.2. By Indication
7.3.5.2.3. By Dosage Form
7.3.5.2.4. By Route of Administration
7.3.5.2.5. By End Users
8. Asia-Pacific Chemotherapy Market Outlook
8.1. Market Size & Forecast
8.1.1. By Value
8.2. Market Share & Forecast
8.2.1. By Type
8.2.2. By Indication
8.2.3. By Dosage Form
8.2.4. By Route of Administration
8.2.5. By End Users
8.2.6. By Country
8.3. Asia-Pacific: Country Analysis
8.3.1. China Chemotherapy Market Outlook
8.3.1.1. Market Size & Forecast
8.3.1.1.1. By Value
8.3.1.2. Market Share & Forecast
8.3.1.2.1. By Type
8.3.1.2.2. By Indication
8.3.1.2.3. By Dosage Form
8.3.1.2.4. By Route of Administration
8.3.1.2.5. By End Users
8.3.2. India Chemotherapy Market Outlook
8.3.2.1. Market Size & Forecast
8.3.2.1.1. By Value
8.3.2.2. Market Share & Forecast
8.3.2.2.1. By Type
8.3.2.2.2. By Indication
8.3.2.2.3. By Dosage Form
8.3.2.2.4. By Route of Administration
8.3.2.2.5. By End Users
8.3.3. Japan Chemotherapy Market Outlook
8.3.3.1. Market Size & Forecast
8.3.3.1.1. By Value
8.3.3.2. Market Share & Forecast
8.3.3.2.1. By Type
8.3.3.2.2. By Indication
8.3.3.2.3. By Dosage Form
8.3.3.2.4. By Route of Administration
8.3.3.2.5. By End Users
8.3.4. South Korea Chemotherapy Market Outlook
8.3.4.1. Market Size & Forecast
8.3.4.1.1. By Value
8.3.4.2. Market Share & Forecast
8.3.4.2.1. By Type
8.3.4.2.2. By Indication
8.3.4.2.3. By Dosage Form
8.3.4.2.4. By Route of Administration
8.3.4.2.5. By End Users
8.3.5. Australia Chemotherapy Market Outlook
8.3.5.1. Market Size & Forecast
8.3.5.1.1. By Value
8.3.5.2. Market Share & Forecast
8.3.5.2.1. By Type
8.3.5.2.2. By Indication
8.3.5.2.3. By Dosage Form
8.3.5.2.4. By Route of Administration
8.3.5.2.5. By End Users
9. South America Chemotherapy Market Outlook
9.1. Market Size & Forecast
9.1.1. By Value
9.2. Market Share & Forecast
9.2.1. By Type
9.2.2. By Indication
9.2.3. By Dosage Form
9.2.4. By Route of Administration
9.2.5. By End Users
9.2.6. By Country
9.3. South America: Country Analysis
9.3.1. Brazil Chemotherapy Market Outlook
9.3.1.1. Market Size & Forecast
9.3.1.1.1. By Value
9.3.1.2. Market Share & Forecast
9.3.1.2.1. By Type
9.3.1.2.2. By Indication
9.3.1.2.3. By Dosage Form
9.3.1.2.4. By Route of Administration
9.3.1.2.5. By End Users
9.3.2. Argentina Chemotherapy Market Outlook
9.3.2.1. Market Size & Forecast
9.3.2.1.1. By Value
9.3.2.2. Market Share & Forecast
9.3.2.2.1. By Type
9.3.2.2.2. By Indication
9.3.2.2.3. By Dosage Form
9.3.2.2.4. By Route of Administration
9.3.2.2.5. By End Users
9.3.3. Colombia Chemotherapy Market Outlook
9.3.3.1. Market Size & Forecast
9.3.3.1.1. By Value
9.3.3.2. Market Share & Forecast
9.3.3.2.1. By Type
9.3.3.2.2. By Indication
9.3.3.2.3. By Dosage Form
9.3.3.2.4. By Route of Administration
9.3.3.2.5. By End Users
10. Middle East and Africa Chemotherapy Market Outlook
